What Researchers Did
The authors searched PubMed and Google Scholar for articles published from November 2021 to January 2024 that mentioned long COVID and hyperbaric oxygen, and reviewed them.
What They Found
This literature review of published studies, including case series and randomized trials, reports that hyperbaric oxygen therapy (HBO) was linked to significant improvement in patients with long COVID. The abstract does not give the number of studies, the number of patients, the pressures used, the number of sessions, or any statistical results. It states that no current therapeutics are effective in treating the underlying pathophysiology of long COVID. It also says an estimated 50 million people have long COVID and report low health-related quality of life. The authors describe HBO as a safe treatment that may provide benefit and should continue to be researched as an adjunctive treatment.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a review that pools findings from published case series and randomized trials, and the abstract reports no sample sizes, statistics or quality assessment of those studies, so it cannot show how strong the evidence is or whether HBO caused the improvements.